Rubicon Advisors, GP: MRNA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rubicon Advisors, GP on MRNA, newest first. How the timeline and the estimate are built.
Rubicon Advisors, GP held 2,035 MRNA shares at 2026-09-30 per its 13F-HR filed 2026-10-23.
the latest 13F is the newest step
- period ended2026-09-3013F 2,035 sharesChange vs previous 13F not available
0.27% of the 13F portfolio, value $391,881.
13F-HR 0001172661-26-004655 filed by Rubicon Advisors, GP
Accepted , ingested